Science Corp raises $400 million at $3.5B valuation

bloomberg.com1 min read

Science Corp, the developer of a retinal chip designed to restore vision for people with an age-related form of blindness, has reached a $3.5 billion valuation following a $400 million fundraising round. The company states the new capital will support the ongoing development of its blindness-treating implants and neural devices powered by engineered cells. Investors in this funding round include Khosla Ventures, Tenet Healthcare Corp., and the Ackman Oxman Institute. Open article →